凯中精密(002823) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 was ¥720,104,006.64, a decrease of 3.21% compared to ¥743,975,040.57 in the same period last year[4] - Net profit attributable to shareholders increased by 75.51% to ¥49,050,011.28 from ¥27,947,714.17 year-on-year[4] - Basic earnings per share rose by 60.00% to ¥0.16, compared to ¥0.10 in the same period last year[4] - The company reported a net profit margin improvement due to reduced operating costs, although specific profit figures were not disclosed[16] - The company's net profit for the current period is CNY 49,050,011.28, a significant increase from CNY 27,947,714.17 in the previous period, representing an increase of approximately 75.5%[17] - Operating profit reached CNY 64,623,193.43, compared to CNY 30,100,039.77 in the prior period, indicating a growth of about 114.5%[17] - Total revenue from operating activities amounted to CNY 734,018,415.64, slightly up from CNY 728,936,937.90 year-on-year[19] - The company’s total comprehensive income for the current period is CNY 62,237,123.13, compared to CNY 24,730,355.54 in the previous period, marking an increase of about 151.5%[18] Cash Flow and Expenses - The net cash flow from operating activities surged by 688.21% to ¥101,150,704.88, up from ¥12,832,934.99 in the previous year[4] - The company incurred financial expenses of CNY 5,558,535.88, down from CNY 20,301,604.59, indicating a decrease of approximately 72.6%[17] - Cash and cash equivalents at the end of the period totaled CNY 111,256,374.21, down from CNY 183,790,622.25, a decrease of about 39.3%[20] - The company’s investment activities resulted in a net cash outflow of CNY 31,830,054.44, compared to a net outflow of CNY 88,894,907.86 in the previous period[20] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,578,997,386.53, reflecting a 0.42% increase from ¥3,563,923,727.47 at the end of the previous year[4] - The company's equity attributable to shareholders increased by 3.24% to ¥1,985,922,589.01 from ¥1,923,685,465.88[4] - Total liabilities decreased to RMB 1,593,074,797.52 from RMB 1,640,238,261.59, a reduction of 2.9%[15] - The expected liabilities increased by 762.57% to ¥4,653,436.58, attributed to the rise in pending litigation[7] Operating Costs and Revenue - Total operating revenue for the period was RMB 720,104,006.64, a decrease of 3.9% compared to RMB 743,975,040.57 in the previous period[16] - Total operating costs decreased to RMB 656,925,515.37 from RMB 717,615,425.44, reflecting a reduction of 8.5%[16] - Research and development expenses decreased to CNY 18,020,261.49 from CNY 22,841,276.75, reflecting a reduction of approximately 21.2%[17] Inventory and Receivables - Inventory increased slightly to RMB 488,546,258.39 from RMB 486,579,177.97, indicating a marginal growth of 0.2%[14] - Accounts receivable increased to RMB 507,166,535.25 from RMB 493,321,481.79, showing an increase of 2.8%[13] - The company recorded a significant increase in accounts receivable financing, which rose by 311.91% to ¥26,747,261.56 from ¥6,493,548.36[7] Government Support and Future Outlook - The company received government subsidies amounting to ¥4,487,109.32, which are closely related to its normal business operations[5] - Future outlook includes potential market expansion and new product development strategies, although specific details were not provided in the call[16]